Skip to content

Hyperbaric oxygen therapy for the brain fog of long COVID

Hyperbaric oxygen therapy for the brain fog of long COVID

Status
Unknown
Phases
Unknown
Study type
Interventional
Source
CRIS
Registry ID
KCT0007654
Enrollment
50
Registered
2022-08-17
Start date
2022-11-08
Completion date
Unknown
Last updated
2022-11-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Procedure/Surgery : Hyperbaric Oxygen therapy Dose: 2 atmospheres for 90 minutes (Including airbrake for 5 minutes, every 20 minutes) session: 10 sessions period: 2 weeks(once daily with a 2day break

Sponsors

Myongji Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1) More than 12 weeks have passed since the date of COVID-19 confirmed by RT-PCR 2) Brain fog symptoms occurred within 6 months of being confirmed by the COVID-19 and have persisted until now. 3) Age between 30 ~70 yrs 4) Proficient in Korean 5) A person who has consented to this participation and prepared a written consent before the start of the human application test

Exclusion criteria

Exclusion criteria: 1) History of head trauma accompanied by loss of consciousness, stroke, epilepsy, dementia and other brain diseases 2) Currently undergoing cancer treatment (surgery, chemotherapy, radiation) 3) Serious heart disease (myocardial infarction, angina pectoris, severe arrhythmia), lung disease (chronic obstructive pulmonary disease, emphysema, asthma, pneumothorax), and other serious medical conditions 4) Currently alcoholic or drug dependent, or have been diagnosed with schizophrenia. 5) Otitis media, severe rhinitis, and problems with normal ear pressure control 6) A person judged by the investigator to be inappropriate for this human application test

Design outcomes

Primary

MeasureTime frame
Changes in T score of 5 items of cognitive test;Changes in the total score of 5 survey items;Results of immune marker (ESR, CRP, cytokine assay (IL-2, IL-6, IL-8, IL-10))

Secondary

MeasureTime frame
Results of immune marker (ESR, CRP, cytokine assay (IL-2, IL-6, IL-8, IL-10))

Countries

Korea, Republic of

Contacts

Public ContactJhingoo Chang

Myongji Hospital

realishia@hanmail.net+82-2-810-5114

Outcome results

None listed

Source: CRIS (via WHO ICTRP) · Data processed: Feb 4, 2026